Trials / Recruiting
RecruitingNCT06554652
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Tracer Navigated Selective Neck Dissection Versus Modified Neck Dissection in Papillary Thyroid Cancer With Limited Lymph Node Metastasis in the Lateral Neck: A Randomized, Noninferiority Phase III Trial
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 14 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental group (selective neck dissection) or the control group (modified neck dissection), with LRFS as the primary endpoint. The aim of the study is to evaluate the safety of selective neck dissection in papillary carcinoma with limited number of lymph node metastases in the lateral neck, and the quality of life compared with modified neck dissection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lymph node tracer navigated selective neck dissection | Selective lateral lymph node dissection (after injection of tracer, lymph nodes in compartment III-IV are dissected; if there is dyed lymph node in compartment IIA, then IIA is dissected). |
| PROCEDURE | Modified neck dissection | Lymph nodes in compartment IIA, IIB, III, IV, VB are dissected. |
Timeline
- Start date
- 2024-11-19
- Primary completion
- 2029-06-30
- Completion
- 2029-06-30
- First posted
- 2024-08-15
- Last updated
- 2026-02-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06554652. Inclusion in this directory is not an endorsement.